- Home
- CGCT vs NYXH Comparison
CGCT vs NYXH Comparison
Compare CGCT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGCT
- NYXH
- Stock Information
- Founded
- CGCT 2024
- NYXH 2009
- Country
- CGCT United States
- NYXH Belgium
- Employees
- CGCT N/A
- NYXH N/A
- Industry
- CGCT
- NYXH Medical/Dental Instruments
- Sector
- CGCT
- NYXH Health Care
- Exchange
- CGCT NYSE
- NYXH Nasdaq
- Market Cap
- CGCT 346.6M
- NYXH 290.9M
- IPO Year
- CGCT 2025
- NYXH 2021
- Fundamental
- Price
- CGCT $10.06
- NYXH $7.12
- Analyst Decision
- CGCT
- NYXH Strong Buy
- Analyst Count
- CGCT 0
- NYXH 4
- Target Price
- CGCT N/A
- NYXH $14.50
- AVG Volume (30 Days)
- CGCT 11.1K
- NYXH 38.4K
- Earning Date
- CGCT 01-01-0001
- NYXH 08-18-2025
- Dividend Yield
- CGCT N/A
- NYXH N/A
- EPS Growth
- CGCT N/A
- NYXH N/A
- EPS
- CGCT N/A
- NYXH N/A
- Revenue
- CGCT N/A
- NYXH $4,716,818.00
- Revenue This Year
- CGCT N/A
- NYXH $209.22
- Revenue Next Year
- CGCT N/A
- NYXH $219.37
- P/E Ratio
- CGCT N/A
- NYXH N/A
- Revenue Growth
- CGCT N/A
- NYXH N/A
- 52 Week Low
- CGCT $10.00
- NYXH $5.55
- 52 Week High
- CGCT $11.16
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- CGCT N/A
- NYXH 37.94
- Support Level
- CGCT N/A
- NYXH $7.05
- Resistance Level
- CGCT N/A
- NYXH $7.59
- Average True Range (ATR)
- CGCT 0.00
- NYXH 0.30
- MACD
- CGCT 0.00
- NYXH -0.10
- Stochastic Oscillator
- CGCT 0.00
- NYXH 5.66
About CGCT CARTESIAN GROWTH CORP III
Cartesian Growth Corp III is a blank check company.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.